ACS is a cancer organization based in Atlanta, GA that was founded in 1922. As of 2019 they had $769 million in revenue and $1.6 billion in assets.
To eliminate Cancer as a major health problem by preventing Cancer, saving lives, and diminishing suffering from the disease, through research, education, advocacy, and service. Through our 11 geogragraphic divisions & nationwide corporate center, we ...
Previous legal names or variations of their name include: National Home Office.
EIN:
13-1788491
City:
State:
Website:
Facebook:
Twitter:
Founded:
1922
Type:
501(c)(3)
NTEE:
Revenue:
$769,888,861
Assets:
$1,634,380,835
Employees:
5,160
Fiscal year end:
December
Program areas at ACS
Research programs provide financial support to fund and conduct research into the causes of Cancer; how it can be prevented, detected early, and treated successfully; how to improve the quality of life for people living with Cancer; and to advocate for laws and policies that help further Cancer research. Our research program expenses included both our extramural research grants and intramural program, which included our comprehensive Cancer prevention study (cps-3).
Prevention programs provide the public and health professionals with information and education to prevent Cancer occurrence and to reduce the risk of developing Cancer. Prevention expenses included activities such as our ongoing advocacy efforts to increase certain state tobacco taxes through our grants to affiliates and promoting the human papillomavirus (hpv) vaccination in addition to general prevention work.
Patient support programs assist Cancer patients and their families in an effort to ease the burden of the disease for them. Expenses included our specific assistance to individuals through the look good feel better program; our 24 hours a day, 7 days a week, 365 days a year national Cancer information center; and our hope lodge facilities, which provide free, high quality, temporary lodging for patients and their caregivers close to treatment centers, thereby easing the emotional and financial burden of finding affordable lodging.
Form 990s for ACS
| Fiscal year ending | Date received by IRS | Form | PDF link |
|---|
| 2018-12 | Feb 7, 2020 | 990 | View PDF |
| 2017-12 | Mar 15, 2019 | 990 | View PDF |
| 2016-12 | Oct 25, 2017 | 990 | View PDF |
| 2015-12 | Mar 28, 2017 | 990 | View PDF |
| 2014-12 | Oct 2, 2015 | 990 | View PDF |
| ...and seven more Form 990 PDFs |
Financials for ACS
| Field | 2018 | 2017 | % Change |
|---|
| Federated campaigns | $4,132,867 | $5,139,160 | -19.6% |
| Membership dues | $0 | $0 | |
| Fundraising event contributions | $301,025,924 | $338,089,492 | -11.0% |
| Related organizations | $0 | $0 | |
| Government grants (contributions) | $5,392,503 | $5,349,186 | 0.8% |
| Normal grants, contributions, etc. | $402,709,077 | $358,968,514 | 12.2% |
| <em>Non-cash contributions included in above</em> | $55,941,119 | $42,489,806 | 31.7% |
| Total grants, contributions, etc. | $713,260,371 | $707,546,352 | 0.8% |
| Field | 2018 | 2017 | % Change |
|---|
| Total grants, contributions, etc. | $713,260,371 | $707,546,352 | 0.8% |
| Program services | $28,772 | $11,620 | 147.6% |
| Investment income and dividends | $24,726,533 | $25,393,026 | -2.6% |
| Tax-exempt bond proceeds | $0 | $0 | |
| Royalty revenue | $4,084,012 | $4,362,604 | -6.4% |
| Net rental income | $613,097 | $556,658 | 10.1% |
| Net gain from sale of non-inventory assets | $33,001,780 | $56,080,847 | -41.2% |
| Net income from fundraising events | $0 | $0 | |
| Net income from gaming activities | $1,373,030 | $1,422,388 | -3.5% |
| Net income from sales of inventory | $-13,108,731 | $-12,610,197 | -4.0% |
| Miscellaneous revenues | $5,909,997 | $5,793,642 | 2.0% |
| Total revenues | $769,888,861 | $788,556,940 | -2.4% |
| Field | 2018 | 2017 | % Change |
|---|
| Grants to govts. and orgs. in USA | $139,506,206 | $144,897,982 | -3.7% |
| Grants to individuals in USA | $27,546,309 | $20,857,299 | 32.1% |
| Grants to govts., orgs., and individuals outside USA | $3,189,019 | $2,295,770 | 38.9% |
| Benefits paid to or for members | $0 | $0 | |
| Compensation of current officers, etc. | $4,307,122 | $6,304,613 | -31.7% |
| Compensation not included above, to disqualified persons | $282,344 | $602,204 | -53.1% |
| Non-officer salaries and wages | $261,159,199 | $300,654,365 | -13.1% |
| Pension/retirement accruals and contributions | $7,586,425 | $25,728,758 | -70.5% |
| Other employee benefits | $32,571,502 | $39,345,757 | -17.2% |
| Payroll taxes | $20,698,449 | $22,940,810 | -9.8% |
| Management fees | $692,593 | $999,549 | -30.7% |
| Legal fees | $4,658,997 | $2,704,172 | 72.3% |
| Accounting fees | $480,760 | $327,865 | 46.6% |
| Lobbying fees | $1,748 | $0 | 999% |
| Pro. fundraising fees | $11,588,368 | $12,684,825 | -8.6% |
| Investment mgmt fees | $1,733,958 | $2,799,263 | -38.1% |
| Other fee-for-service | $36,773,081 | $41,525,833 | -11.4% |
| Advertising and promotion | $33,775,936 | $35,727,072 | -5.5% |
| Office expenses | $30,826,133 | $32,788,220 | -6.0% |
| Information tech. expenses | $24,362,748 | $26,195,484 | -7.0% |
| Royalty expenses | $0 | $0 | |
| Occupancy | $45,709,023 | $42,830,158 | 6.7% |
| Travel | $12,333,591 | $13,770,346 | -10.4% |
| Public official travel and entertainment | $0 | $0 | |
| Conferences, meetings, etc. | $6,099,290 | $6,879,020 | -11.3% |
| Interest | $1,176,100 | $880,516 | 33.6% |
| Payments to affiliates | $0 | $0 | |
| Depreciation, amortization, etc. | $14,005,370 | $15,105,964 | -7.3% |
| Insurance | $2,770,379 | $2,962,168 | -6.5% |
| All other expenses | $16,741,120 | $11,821,319 | 41.6% |
| Total expenses | $740,575,770 | $813,629,332 | -9.0% |
| Field | 2018 | 2017 | % Change |
|---|
| Cash (non-interest-bearing) | $0 | $0 | |
| Savings, short-term investments, etc. | $63,089,707 | $109,520,975 | -42.4% |
| Pledges and grants receivable | $85,327,830 | $66,259,287 | 28.8% |
| Accounts receivable | $5,314,746 | $5,871,687 | -9.5% |
| Loans receivable from officers, directors, etc. | $0 | $0 | |
| Loans receivable from other disqualified persons | $0 | $0 | |
| Notes and loans receivable | $0 | $0 | |
| Inventories for use | $3,326,496 | $3,070,580 | 8.3% |
| Prepaid expenses and deferred charges | $11,122,184 | $9,774,985 | 13.8% |
| Buildings, equipment, etc. post-depreciation | $228,538,611 | $220,446,954 | 3.7% |
| Investments, publicly traded securities | $818,113,845 | $835,661,013 | -2.1% |
| Investments, other securities | $0 | $0 | |
| Investments, program-related | $0 | $0 | |
| Intangible assets | $0 | $0 | |
| Other assets | $419,547,416 | $447,052,529 | -6.2% |
| Total assets | $1,634,380,835 | $1,697,658,010 | -3.7% |
| Field | 2018 | 2017 | % Change |
|---|
| Accounts payable and accrued expenses | $250,565,099 | $281,140,082 | -10.9% |
| Grants payable | $205,562,698 | $205,877,076 | -0.2% |
| Deferred revenue | $5,371,490 | $11,158,665 | -51.9% |
| Tax-exempt bond liabilities | $0 | $4,055,000 | -100% |
| Escrow or custodial account liability | $0 | $0 | |
| Loans payable to officers and disqualified persons | $0 | $0 | |
| Secured mortgages and notes payable to unrelated third parties | $33,186,691 | $34,851,280 | -4.8% |
| Unsecured notes and loans payable to unrelated third parties | $0 | $0 | |
| Other liabilities | $47,171,191 | $45,712,666 | 3.2% |
| Total liabilities | $541,857,169 | $582,794,769 | -7.0% |
| Field | 2018 | 2017 | % Change |
|---|
| Unrestricted net assets | $464,783,055 | $482,191,383 | -3.6% |
| Temporarily restricted net assets | $320,704,806 | $330,981,308 | -3.1% |
| Permanently restricted net assets | $307,035,805 | $301,690,550 | 1.8% |
Vendors for ACS
| Vendor | Services | Amount paid | Date |
|---|
| Ernst and Young Us LLP | Tax accounting; Audit accounting | | 2020-02-07 |
| ███ ████████ | Claims processing | $10,873,239 | 2019-12-31 |
| ███ ██████████ ███ | Insurance agent or broker; Actuarial services | $112 | 2019-12-31 |
| █████ | Claims processing, Contract Administrator, Named fiduciary, Participant communication | $2,075,993 | 2019-12-31 |
| ██████ ███████ ████ | Insurance | | 2019-12-31 |
| █████████ | Claims processing, Plan Administrator | $112,848 | 2019-12-31 |
| ███████ █████████ ████████ | Insurance agent or broker | $509 | 2019-12-31 |
| ████ | Insurance | | 2019-12-31 |
| ...and 34 more vendors |
Personnel at ACS
| Name | Title | Compensation | Most recent data |
|---|
| Gary M. Reedy | Chief Executive Officer | $884,069 | Aug. 15, 2020 |
| Kris Kim | Chief Operating Officer | - | Aug. 15, 2020 |
| ████ ██████ | Chief Financial Officer | - | Aug. 15, 2020 |
| ██████ █████ | Chief Development, Marketing and Communications Officer | $617,872 | July 17, 2019 |
| █████████ ██████ | Chief Administrative Officer | $405,071 | Feb. 7, 2020 |
| ███████ ██ ██████ | Chief Cancer Control Officer | $502,804 | July 17, 2019 |
| ███████ ██ █████ | Chief Medical and Scientific Officer | - | Aug. 15, 2020 |
| ███████ ████████ | Chief Legal and Risk Officer | $324,757 | Aug. 15, 2020 |
| ███████ ██ ████ | Senior Executive Vice President, Field Operations | $491,092 | July 17, 2019 |
| ████ ████████ | Senior Vice President, Talent Strategy | - | July 17, 2019 |
| ...and 21 more key personnel |
Peer cancer nonprofits
| | Name | Type | Revenue | Location |
|---|
| 1 | Dana-Farber Cancer Institute | 501(c)(3) | $1.9 billion | Boston, MA |
| 2 | The Leukemia and Lymphoma Society | 501(c)(3) | $396 million | Rye Brook, NY |
| 3 | National Multiple Sclerosis Society | 501(c)(3) | $196 million | New York, NY |
| 4 | Fred Hutch (FHCRC) | 501(c)(3) | $698 million | Seattle, WA |
| 5 | Beckman Research Institute of the City of Hope (BRI) | 501(c)(3) | $568 million | Duarte, CA |
| 6 | Seattle Cancer Care Alliance (SCCA) | 501(c)(3) | $757 million | Seattle, WA |
| 7 | St Jude Children's Research Hospital | 501(c)(3) | $1.1 billion | Memphis, TN |
| 8 | City of Hope National Medical Center | 501(c)(3) | $1.3 billion | Duarte, CA |
| 9 | Juvenile Diabetes Research Foundation (JDRF) | 501(c)(3) | $239 million | New York, NY |
| 10 | The Broad Institute | 501(c)(3) | $536 million | Cambridge, MA |
| 11 | Alzheimer's Association | 501(c)(3) | $389 million | Chicago, IL |
| 12 | Jackson Laboratory | 501(c)(3) | $432 million | Bar Harbor, ME |
| 13 | Be The Match / National Marrow Donor Program | 501(c)(3) | $445 million | Minneapolis, MN |
| 14 | Scripps Research Institute | 501(c)(3) | $412 million | La Jolla, CA |
| 15 | Henry M Jackson Foundation For The Advancement of Military Medicine | 501(c)(3) | $495 million | Bethesda, MD |
| 16 | Cold Spring Harbor Laboratory | 501(c)(3) | $212 million | Cold Spring Harbor, NY |
| 17 | Weizmann Institute of Science | 501(c)(3) | $613 million | Israel, |
| 18 | Cystic Fibrosis Foundation | 501(c)(3) | $275 million | Bethesda, MD |
| 19 | Musculoskeletal Transplant Foundation (MTF) | 501(c)(3) | $431 million | Edison, NJ |
| 20 | Purdue Research Foundation (PRF) | 501(c)(3) | $195 million | West Lafayette, IN |
| 21 | Health Scholarships of Georgia | 501(c)(3) | $248 million | Gray, GA |
| 22 | Cooperative for Assistance and Relief EVERYWHERE | 501(c)(3) | $620 million | Atlanta, GA |
| 23 | Elizabeth Glaser Pediatric Aids Foundation | 501(c)(3) | $199 million | Washington, DC |
| 24 | Harmony Public Schools | 501(c)(3) | $366 million | Houston, TX |
| 25 | Howard Hughes Medical Institute | 501(c)(3) | $1.4 billion | Chevy Chase, MD |